The next hero cannabinoid
CBG (Cannabigerol) is the precursor from which all other cannabinoids are synthesized and has exciting therapeutic potential to address consumer skincare concerns. To date, cannabinoids have been extracted directly from hemp plants, which require significant land usage, are difficult to scale, and often have regulatory risks related to THC.
Using biotechnology and sugarcane fermentation, Amyris produces clean CBG, without the hemp plant. This process guarantees no THC in the final product and therefore, carries no regulatory risk or challenges related to THC. Additionally, the entire process ensures environmental and social responsibility, starting with its Bonsucro-certified sugarcane feedstock in the fermentation process.
Initial studies demonstrate Amyris’ CBG provides benefits to address common skincare conditions like dry skin, irritation, and redness. Now, brands can formulate a completely new variety of oils, creams, lotions, and more with the promising benefits of Amyris’ clean CBG.